bretylium has been researched along with Dermatitis Medicamentosa in 1 studies
bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuczkowski, KM | 1 |
1 other study available for bretylium and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Bretylium in the treatment of complex regional pain syndrome: uncommon side-effect of a common drug.
Topics: Adult; Autonomic Nerve Block; Bretylium Compounds; Complex Regional Pain Syndromes; Drug Eruptions; | 2003 |